53. シェーグレン症候群 Sjogren syndrome Clinical trials / Disease details


臨床試験数 : 283 薬物数 : 328 - (DrugBank : 101) / 標的遺伝子数 : 55 - 標的パスウェイ数 : 180

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05016297
(ClinicalTrials.gov)
October 15, 202126/6/2021Efficacy and Safety of Baricitinib in Sjogren's SyndromeA Multi-center, Prospective, Open-label, Randomized Study to Explore Efficacy and Safety of Baricitinib in Active Primary Sjogren's Syndrome PatientsSjogren's SyndromeDrug: Baricitinib;Drug: HydroxychloroquinePeking Union Medical College HospitalEli Lilly and CompanyNot yet recruiting18 Years75 YearsAll87Phase 2China
2NCT04916756
(ClinicalTrials.gov)
January 16, 20201/6/2021A Prospective Pilot Study to Explore Efficacy and Safety of Baricitinib in Active Primary Sjogren's Syndrome PatientsA Prospective Pilot Study to Explore Efficacy and Safety of Baricitinib in Active Primary Sjogren's Syndrome PatientsSjogren's SyndromeDrug: Baricitinib 2 MGPeking Union Medical College HospitalNULLCompleted18 YearsN/AAll11Phase 1/Phase 2China